Vanderbilt University Medical Center — Nashville, Tennessee

Public research footprint of Vanderbilt University Medical Center, compiled from the ClinicalTrials.gov public registry.

2,413

Registered studies

675

Active

361

Recruiting now

1,335

Completed

352

Stopped or withdrawn

Most-studied conditions

Acute Respiratory Distress Syndrome (ARDS) · Locally Advanced Unresectable Gastroesophageal Junction (GEJ)… · Non-muscle Invasive Bladder Cancer (NMIBC) · Paroxysmal Atrial Fibrillation (PAF)

Recently updated registry entries

NCT03767244 — A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced… (Active Not Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT06901531 — A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With… (Recruiting)

Work at Vanderbilt University Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.